Back to search
FDAFDA · Food and drugs·Recall number D-0876-2026

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

Published October 7, 2026 · Recall initiated: September 8, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
BUPRENORPHINE HYDROCHLORIDE
Manufacturer
Par Health USA, LLC
Distributor
U.S. Nationwide
Lot
Lot#:83912, Exp Date 10/2026 Lot#:84234, Exp Date 11/2026 Lot#:84990, Exp Date 11/2026 Lot#:85003, Exp Date 12/2026 Lot#:86443, Exp Date 01/2027 Lot#:89909, Exp Date 05/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05 recalled?

Yes. FDA published recall D-0876-2026 on October 7, 2026. Reported hazard: Crystallization

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPRENORPHINE HYDROCHLORIDE.

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Recalert also tracks expiration dates so you can sell stock before it becomes a loss.

Check your inventory (free)